https://www.selleckchem.com/pr....oducts/semaxanib-su5
All patients with positive margins had re-recurrence. Four patients required repeat endoscopic nasopharyngectomy and two received chemoradiation. All four with a second endoscopic procedure had further disease recurrence. Five-year local disease-free and overall survival rates were 53.9 and 84.6%, respectively. The minor complication rate was 52.6%, major operative complication rate was 0.0%, and late complication rate was 23.1%. Endoscopic nasopharyngectomy demonstrates promising 5-year overall survival rate for rT1 and rT2 ca
Like
Comment
Share
